Avanza Medical Research Center | Gulf Coast Office Center

Research site

(Unclaimed)

Location

4700 Bayou Blvd Suite 4, Pensacola, Florida, United States of America

Site insights

Top conditions

Top treatments

BMS-986278

Lasmiditan

LY573144

Baloxavir Marboxil

Lunsekimig

Galcanezumab

Iron

SAR440340

SAR443765

GFB-887

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 24 total trials

A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine (REBUILD-2)

The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participant...

Active, not recruiting

Chronic Migraine

Drug: Placebo

Drug: Galcanezumab

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine (REBUILD-1)

The main purpose of this study is to evaulate the efficacy and safety of galcanezumab in participants 6 to 17 years of age for the preventive treatme...

Active, not recruiting

Episodic Migraine

Drug: Galcanezumab

Drug: Placebo

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

The purpose of this study is to assess the safety and efficacy of brenipatide at different dose levels compared with placebo in participants with mod...

Enrolling

Asthma

Drug: Brenipatide

Drug: Placebo

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in participants with Idiopathic Pulmonary Fibrosis.

Active, not recruiting

Idiopathic Pulmonary Fibrosis

Drug: BMS-986278

Drug: BMS-986278 Placebo

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.

Active, not recruiting

Progressive Pulmonary Fibrosis

Drug: BMS-986278 Placebo

Drug: BMS-986278

A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts (Pebblestone)

This study consists of two parts: Part A Surveillance and Part B Transmission.The main purpose of Part A is to evaluate the prevalence of pre-dose an...

Enrolling

Influenza

Drug: Baloxavir Marboxil

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype (THESEUS)

This is a parallel, Phase 2/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig...

Enrolling

Chronic Obstructive Pulmonary Disease

Drug: Placebo

Drug: Lunsekimig

Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma (AIRLYMPUS)

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this study is...

Enrolling

Asthma

Drug: Budesonide/Albuterol

Drug: Lunsekimig